Holen Sie sich die Stockscreener-App
13.85
0.36%
-0.07
Handel nachbörslich:
13.85
Schlusskurs vom Vortag:
$13.92
Offen:
$14
24-Stunden-Volumen:
292.55K
Relative Volume:
0.78
Marktkapitalisierung:
$697.50M
Einnahmen:
$62.02M
Nettoeinkommen (Verlust:
$-45.65M
KGV:
-15.05
EPS:
-0.92
Netto-Cashflow:
$-9.60M
1W Leistung:
-3.34%
1M Leistung:
-3.01%
6M Leistung:
+58.88%
1J Leistung:
+68.53%
1-Tages-Spanne:
$13.82
$14.28
1-Wochen-Bereich:
$13.75
$14.62
52-Wochen-Spanne:
$7.90
$15.15
Theravance Biopharma Inc Stock (TBPH) Company Profile
Firmenname
Theravance Biopharma Inc
Sektor
Branche
Telefon
650-808-6000
Adresse
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Vergleichen Sie TBPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TBPH
Theravance Biopharma Inc
|
13.85 | 701.03M | 62.02M | -45.65M | -9.60M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-12 | Eingeleitet | B. Riley Securities | Buy |
| 2024-08-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-04-12 | Eingeleitet | BTIG Research | Buy |
| 2024-01-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-05-23 | Eingeleitet | SVB Leerink | Outperform |
| 2021-11-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2021-08-25 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2021-08-24 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-10-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-07 | Eingeleitet | JP Morgan | Overweight |
| 2020-06-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-05-13 | Eingeleitet | Cowen | Outperform |
| 2020-01-08 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-06 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2019-10-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-29 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-06-16 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-05-11 | Bestätigt | Needham | Buy |
| 2016-12-21 | Eingeleitet | Needham | Buy |
| 2016-11-03 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-10-12 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2016-08-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2016-06-20 | Eingeleitet | Guggenheim | Buy |
| 2016-06-20 | Bestätigt | Leerink Partners | Outperform |
| 2016-05-12 | Eingeleitet | Leerink Partners | Outperform |
| 2016-05-05 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2015-02-03 | Hochstufung | Robert W. Baird | Underperform → Neutral |
Alle ansehen
Theravance Biopharma Inc Aktie (TBPH) Neueste Nachrichten
How to integrate Theravance Biopharma Inc. into portfolio analysis toolsWeekly Profit Report & Expert Approved Trade Ideas - newser.com
Theravance to present new YUPELRI data at CHEST 2025 annual meeting - Investing.com
Theravance Biopharma Presents YUPELRI: Fewer COPD Exacerbations | TBPH Stock News - Stock Titan
Theravance Biopharma Inc. stock volume spike explained2025 Institutional Moves & High Yield Stock Recommendations - newser.com
How to escape a deep drawdown in Theravance Biopharma Inc.2025 Investor Takeaways & Expert Approved Trade Ideas - newser.com
Identifying reversal signals in Theravance Biopharma Inc.2025 Fundamental Recap & Capital Protection Trade Alerts - newser.com
What RSI levels show for Theravance Biopharma Inc. (0TB) stockWeekly Investment Summary & Stock Market Timing Techniques - newser.com
Can Theravance Biopharma Inc. (0TB) stock hit consensus price targetsJuly 2025 Volume & Low Drawdown Investment Ideas - newser.com
Top chart patterns to watch in Theravance Biopharma Inc.Portfolio Performance Summary & Fast Moving Stock Trade Plans - newser.com
Why Theravance Biopharma Inc. stock is in analyst buy zoneTrade Performance Summary & Target Return Focused Stock Picks - newser.com
Can Theravance Biopharma Inc. stock deliver consistent earnings growth2025 Risk Factors & Safe Capital Allocation Plans - newser.com
Will breakout in Theravance Biopharma Inc. lead to full recovery2025 Historical Comparison & Long-Term Capital Growth Strategies - newser.com
Leading vs lagging indicators on Theravance Biopharma Inc. performanceTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com
Theravance Biopharma Hits New 52-Week High of $15.15, Up 67.59% - Markets Mojo
Analysts Set Theravance Biopharma, Inc. (NASDAQ:TBPH) PT at $23.00 - Defense World
Relative strength of Theravance Biopharma Inc. in sector analysisEarnings Recap Report & Entry Point Confirmation Alerts - newser.com
Is Theravance Biopharma Inc. (0TB) stock positioned for secular growthJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com
What analysts say about Theravance Biopharma Inc stockInsider Trading Compliance & Build Capital Safely - earlytimes.in
Theravance Biopharma (NASDAQ:TBPH) Earns "Hold (C)" Rating from Weiss Ratings - MarketBeat
Theravance Biopharma (NASDAQ:TBPH) Earns “Hold (C)” Rating from Weiss Ratings - Defense World
Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Theravance Biopharma (NASDAQ:TBPH) Sets New 12-Month HighTime to Buy? - MarketBeat
Published on: 2025-10-06 07:12:34 - newser.com
Can swing trading help recover from Theravance Biopharma Inc. lossesWeekly Risk Summary & Weekly Watchlist for Hot Stocks - newser.com
Will Theravance Biopharma Inc. benefit from macro trendsJuly 2025 Spike Watch & Low Risk High Win Rate Picks - newser.com
How to manage a losing position in Theravance Biopharma Inc.Watch List & Verified Short-Term Plans - newser.com
Can Theravance Biopharma Inc. (0TB) stock double in coming years2025 Risk Factors & Long-Term Growth Portfolio Plans - newser.com
What insider purchases suggest about Theravance Biopharma Inc. (0TB) stockProduct Launch & Weekly High Conviction Ideas - newser.com
Published on: 2025-10-03 07:08:04 - newser.com
Theravance Biopharma Inc. stock momentum explainedWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Voya Investment Management LLC Reduces Stock Holdings in Theravance Biopharma, Inc. $TBPH - Defense World
Theravance Biopharma, Inc. $TBPH Shares Bought by Ballentine Partners LLC - Defense World
Theravance Biopharma Hits New 52-Week High of $14.87, Up 67.82% - Markets Mojo
Finanzdaten der Theravance Biopharma Inc-Aktie (TBPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):